{
  "trial_id": "NCT00497458",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "written informed consent",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "total mastectomy or lumpectomy for primary breast cancer",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "anastrozole therapy within previous 6 months",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "node negative or positive disease",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "receptor-positive tumors (ER \u226510% of tumor cells)",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "postmenopausal status",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "postmenopausal levels of FSH/LH/E2",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "arthralgia and associated joint symptoms while on anastrozole",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "WBC \u2265 3.0 x 10^9/L, granulocytes \u2265 1.5 X 10^9/L and platelets \u2265 100 x 10^9/L",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "AST/SGOT or ALT/SGPT \u2264 3 times ULN Serum creatinine \u2264 2 times ULN",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "exclusion": [
    {
      "criterion": "metastatic disease",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "diabetes mellitus or glucose intolerance",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "previous or concomitant other malignancy within previous 5 years",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "other non-malignant systemic diseases preventing prolonged follow-up",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "history of coronary artery disease or no history of previous coronary heart disease but at least two other coronary heart disease risk factors",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "patients on hormone replacement therapy within 4 weeks before trial treatment was initiated",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "patients on breast cancer chemoprevention with anti-oestrogens if less than 18 months between stopping and diagnosis of breast cancer",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "known hypersensitivity to any component of testosterone",
      "label": "not_met",
      "evidence": "quote"
    }
  ],
  "notes": "Patient is a 34-year-old woman from Jordan with general and non-specific bones and joints pain. Her past medical and drug history are unremarkable.",
  "_meta": {
    "topic_id": "53",
    "trial_id": "NCT00497458",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}